Topper, Michael
3Lilly Research Laboratories, Eli Lilly & Company, New York, New York.
2 papers on CoChat
Most cited papers
- Verified
Molecular basis for necitumumab inhibition of EGFR variants associated with acquired cetuximab resistance
Bagchi, A., Haidar, J. N., Eastman, S. W., Vieth, M., Topper, M., Iacolina, M. D., Walker, J. M., Forest, A., Shen, Y., Novosiadly, R. D., et al. (2018) · Molecular Cancer Therapeutics
HER2/EGFR in Cancer ResearchLung Cancer Treatments and Mutations
Cited by 60
- Verified
Sequential Deletion of the Integrase (Gag-Pol) Carboxyl Terminus Reveals Distinct Phenotypic Classes of Defective HIV-1
Mohammed, K. D., Topper, M. B., & Muesing, M. A. (2011) · Journal of Virology
HIV Research and TreatmentHIV/AIDS drug development and treatment
Cited by 44
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free